Literature DB >> 15220119

Diagnosing latent tuberculosis infection: turning glitter to gold.

Peter F Barnes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15220119     DOI： 10.1164/rccm.2404004

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

1.  Evaluation of an interferon gamma assay in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis.

Authors:  Cláudia Diniz Lopes Marques; Ângela Luzia Branco Pinto Duarte; Virginia Maria Barros de Lorena; Joelma Rodrigues Souza; Wayner Vieira Souza; Yara de Miranda Gomes; Eduardo Maia Freese de Carvalho
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

2.  Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact.

Authors:  Mustafa Bakir; Kerry A Millington; Ahmet Soysal; Jonathan J Deeks; Serpil Efee; Yasemin Aslan; Davinder P S Dosanjh; Ajit Lalvani
Journal:  Ann Intern Med       Date:  2008-10-20       Impact factor: 25.391

3.  ESAT-6/CFP-10 fusion protein and peptides for optimal diagnosis of mycobacterium tuberculosis infection by ex vivo enzyme-linked immunospot assay in the Gambia.

Authors:  Philip C Hill; Dolly Jackson-Sillah; Annette Fox; Kees L M C Franken; Moses D Lugos; David J Jeffries; Simon A Donkor; Abdulrahman S Hammond; Richard A Adegbola; Tom H M Ottenhoff; Michel R Klein; Roger H Brookes
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

4.  Comparison of quantiferon test with tuberculin skin test for the detection of tuberculosis infection in children.

Authors:  Hatice Onur; Sami Hatipoğlu; Vefik Arıca; Nevin Hatipoğlu; Seçil Gunher Arica
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

5.  Novel M tuberculosis antigen-specific T-cells are early markers of infection and disease progression.

Authors:  Davinder P S Dosanjh; Mustafa Bakir; Kerry A Millington; Ahmet Soysal; Yasemin Aslan; Serpil Efee; Jonathan J Deeks; Ajit Lalvani
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

6.  Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study.

Authors:  Delia Goletti; M Pasquale Parracino; Ornella Butera; Federica Bizzoni; Rita Casetti; Duilio Dainotto; Gianfranco Anzidei; Carla Nisii; Giuseppe Ippolito; Fabrizio Poccia; Enrico Girardi
Journal:  Respir Res       Date:  2007-01-27

7.  Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin test for diagnosis and treatment of Latent Tuberculosis Infection in primary health care workers in Brazil.

Authors:  Rafaela Borge Loureiro; Ethel Leonor Noia Maciel; Rosangela Caetano; Renata Lyrio Peres; Geisa Fregona; Jonathan E Golub; José Ueleres Braga
Journal:  PLoS One       Date:  2019-11-14       Impact factor: 3.240

8.  Serodiagnostic efficacy of Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex, ESAT-6, and CFP-10 in patients with active tuberculosis.

Authors:  Gavish Kumar; Pradeep Kumar Dagur; Prashant Kumar Singh; Hari Shankar; Virendra S Yadav; Vishwa M Katoch; Bharat Bajaj; Rajesh Gupta; Utpal Sengupta; Beenu Joshi
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-01-05       Impact factor: 4.291

9.  Discordance of tuberculin skin test and interferon gamma release assay in recently exposed household contacts of pulmonary TB cases in Brazil.

Authors:  Rodrigo Ribeiro-Rodrigues; Soyeon Kim; Flávia Dias Coelho da Silva; Aleksandra Uzelac; Lauren Collins; Moíses Palaci; David Alland; Reynaldo Dietze; Jerrold J Ellner; Edward Jones-López; Padmini Salgame
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

10.  Interferon-gamma release assay versus tuberculin skin test for latent tuberculosis infection among HIV patients in Brazil.

Authors:  Gislene Maria Botão Kussen; Libera Maria Dalla-Costa; Andrea Rossoni; Sonia Mara Raboni
Journal:  Braz J Infect Dis       Date:  2015-12-17       Impact factor: 3.257
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.